Fujifilm Toyama Chemical Co. Ltd.
Division of Fujifilm Holdings Corp.
fftc.fujifilm.co.jp/en
Latest From Fujifilm Toyama Chemical Co. Ltd.
Asia Deal Watch: ReVance Licenses Chinese Rights To Botox Competitor To Fosun
With Phase III data in 2,800 patients for reducing frown lines, ReVance anticipates filing RT002 for US approval in 2019. ABL licenses two bispecific antibody candidates to TRIGR, while Sun looks to expand in dermatology with Pola buyout.
Pipeline Watch: Phase III Starts With Oxabact, Imeglimin And Favipiravir
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Deal Watch: Ionis Turns To Affiliate Akcea In Amyloidosis
Biohaven restructures its migraine partnership with Bristol to reduce its downstream royalty commitments. Meanwhile, the pharma partners with GRYT Health's cancer app for patient/caregiver insights into cancer therapy.
Merger With Cempra Takes Melinta Public, Will Help Launch Baxdela
In all-stock transaction, troubled Cempra will merge with privately held Melinta to create a fully integrated anti-infectives company.
Company Information
- Industry
- In Vitro Diagnostics
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Molecular Imaging
-
Diagnostic Imaging Equipment & Supplies
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
- Therapeutic Areas
- Cancer
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Toyama Chemical Co. Ltd.
- Fujifilm RI Pharma Co. Ltd.
- Ownership
- Private
- Headquarters
-
Worldwide
-
Asia
-
Pacific Rim
-
Japan
-
Japan
-
Pacific Rim
-
Asia
- Parent & Subsidiaries
- Fujifilm Holdings Corp.
- Senior Management
- Junji Okada, Pres.
- Contact Info
-
Fujifilm Toyama Chemical Co. Ltd.
Phone: (81) 3 5381 3889
14-1, Kyobashi 2-Chome
Chuo-ku
Tokyo ,
Japan
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice